Latest news
Trevi Therapeutics (TRVI) Advances Clinical Trials Amid High Val - GuruFocusGuruFocus · Fri, 07 Aug 2026 00:32:13 GMTTiziana Life Sciences Stock (TLSA) Opinions on Clinical Trial Updates - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 17:37:00 GMTVaxcyte (PCVX) Advances Phase 3 Trials Amid Mixed Market Signals - GuruFocusGuruFocus · Wed, 05 Aug 2026 23:19:50 GMTWW Q2 Deep Dive: Higher-Value Membership Mix and Clinical Growth Drive Strategic Shift - StockStoryStockStory · Wed, 05 Aug 2026 07:00:00 GMTNovo Nordisk Raises Full-Year Outlook Amid Mixed Results - Intellectia AIIntellectia AI · Wed, 05 Aug 2026 03:21:00 GMTLarimar Therapeutics (LRMR) Advances Nomlabofusp Submission Amid Mixed Financial Signals - GuruFocusGuruFocus · Tue, 04 Aug 2026 16:43:18 GMTRYTM Looks 10.9% Undervalued on GF Value™ Amid Mixed Guru and In - GuruFocusGuruFocus · Tue, 04 Aug 2026 12:11:26 GMTORIC Pharmaceuticals (ORIC) Launches Pivotal Phase 3 Trial Amid Mixed Market Signals - GuruFocusGuruFocus · Tue, 04 Aug 2026 05:23:18 GMT